Market Overview

UPDATE: Bank of America Upgrades Magellan Health Services; Raises PO

Share:
Related MGLN
Barclays Raises Price Targets On Healthcare Companies
Earnings Scheduled For February 26, 2015
Magellan completes takeover of 4D Pharmacy (Seeking Alpha)

According to a research report published this morning, Bank of America has upgraded Magellan Health Services (NASDAQ: MGLN) from Underperform to Buy, and raised PO from $44 to $52.

In the report, Bank of America explained, "We are upgrading shares to Buy (from Underperform) and raising our P.O. to $52 (from $44) with a call that MGLN will retain its largest commercial behavioral health customer near term. The BCBS plan has not bid out the book, which comes up for renewal at year end 2012, and taking benefits in house would require longer lead times. This contract accounts for 5% of total revenue, but potentially ~15% of segment profit. MGLN will concede margin, but locking in terms limits contract termination risks ahead of some growth opportunities. Net, high FCF yields compensated for attrition historically, but a 10% FCF yield + 18% current market cap in cash more clearly reflects a discount to fair value today."

Magellan Health Services is currently trading at $43.60.

Latest Ratings for MGLN

DateFirmActionFromTo
Mar 2015BarclaysMaintainsEqual-weight
Feb 2015JefferiesMaintainsHold
Feb 2015BarclaysMaintainsEqualweight

View More Analyst Ratings for MGLN
View the Latest Analyst Ratings

Posted-In: Bank of AmericaAnalyst Color Upgrades Price Target Analyst Ratings

 

Related Articles (MGLN)

Around the Web, We're Loving...